Boeing HorizonX has exited Cuberg three years after investing in the battery cell technology developer.

CommerzBank, Monex Group, Coinbase and Digital Garage are set to exit the digital wallet provider in a Paypal acquisition reportedly sized below $200m.

Grifols has agreed to buy the remaining 56% of antibody drug developer GigaGen having invested $35m four years ago.

The Tencent and Warner Music-backed game development platform looks set to maintain its $29.5bn valuation in its direct listing today.

Motorola Solutions is among the participants supplying $300m in PIPE financing as the contactless security system developer agrees to list through a reverse takeover.

Deutsche Telekom-backed DTCP was among a group of investors that acquired a $270m stake in the cybersecurity management platform developer in a secondary transaction.

Novo will exit the musculoskeletal disease drug developer, should the latter complete an initial public offering on the Nasdaq Global Market.

SR One is line for an exit from the small-molecule therapy developer, which has raised $170m in venture funding in the past year.

Quench Bio will wind down after its protein target proved undruggable and will return capital to investors including AbbVie Ventures.

Metro Group is among the shareholders set to exit the employee management platform developer in an acquisition by accounting technology producer Xero.